May 19, 2020 / 12:30PM GMT
Operator
Welcome to the Revance Therapeutics call discussing the company's acquisition of HintMD. (Operator Instructions) As a reminder, this conference is being recorded today, Tuesday, May 19, 2020. I would now turn the call over to Jeanie Herbert, Senior Director of Investor Relations. Please go ahead.
Jeanie D. Herbert - Revance Therapeutics, Inc. - Senior Director of IR & Corporate Communications
Thank you, Jonathan. With me on today's call from Revance is President and Chief Executive Officer, Mark Foley; Chief Financial Officer, Toby Schilke; and Chief Commercial Officer, Aesthetics & Therapeutics, Dustin Sjuts. This morning, Revance Therapeutics announced the acquisition of HintMD, a privately held company that has developed a proprietary financial technology platform for aesthetic practices. If you have not received the news release and would like to read it or if you'd simply like to be added to the company's distribution list, you can access both at investors.revance.com. Today's conference call includes a slide presentation, which we will reference as
Revance Therapeutics Inc to Acquire HintMD and its Proprietary Fintech Platform for Aesthetic Practices Call Transcript
May 19, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers